Physician profile
David Shane Pendley
NPI 1548217896
$895.61
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.99 · 2020: $336 · 2021: $334 · 2022: $135 · 2024: $28.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $28.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $405.28 | 2019-2022 | |
| Dexcom, INC. | $118.10 | 2021-2022 | |
| Insulet Corporation | $65.67 | 2019-2020 | |
| Lilly USA, LLC | $62.34 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.35 | 2021 | |
| Corcept Therapeutics | $35.70 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $30.48 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $28.80 | 2024 | |
| Xeris Pharmaceuticals, INC. | $24.45 | 2020 | |
| Sanofi-Aventis U.S. LLC | $19.47 | 2021 | |
| Medtronic Minimed, INC. | $17.32 | 2020 | |
| Novo Nordisk INC | $12.69 | 2021 | |
| Medtronic, INC. | $12.56 | 2021 | |
| Companion Medical, INC. | $12.25 | 2019 | |
| Tandem Diabetes Care, INC. | $11.15 | 2020 |
2 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Pendley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.